Literature DB >> 7859740

The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding.

J L Waterman1, J L Shenk, T D Halazonetis.   

Abstract

The p53 tumor suppressor forms stable tetramers, whose DNA binding activity is allosterically regulated. The tetramerization domain is contained within the C-terminus (residues 323-355) and its three-dimensional structure exhibits dihedral symmetry, such that a p53 tetramer can be considered a dimer of dimers. Under conditions where monomeric p53 fails to bind DNA, we studied the effects of p53 C-terminal mutations on DNA binding. Residues 322-355 were sufficient to drive DNA binding of p53 as a tetramer. Within this region residues predicted by the three-dimensional structure to stabilize tetramerization, such as Arg337 and Phe341, were critical for DNA binding. Furthermore, substitution of Leu344 caused p53 to dissociate into DNA binding-competent dimers, consistent with the location of this residue at the dimer-dimer interface. The p53 DNA site contains two inverted repeats juxtaposed to a second pair of inverted repeats. Thus, the four repeats exhibit cyclic-translation symmetry and cannot be recognized simultaneously by four dihedrally symmetric p53 DNA binding domains. The discrepancy may be resolved by flexible linkers between the p53 DNA binding and tetramerization domains. When these linkers were deleted p53 exhibited novel DNA binding properties consistent with an inability to recognize four contiguous DNA repeats. Allosteric regulation of p53 DNA binding may involve repositioning the DNA binding domains from a dihedrally symmetric state to a DNA-bound asymmetric state.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7859740      PMCID: PMC398109          DOI: 10.1002/j.1460-2075.1995.tb07027.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  37 in total

1.  Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation.

Authors:  J Milner; E A Medcalf
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

2.  Formation of stable p53 homotetramers and multiples of tetramers.

Authors:  J E Stenger; G A Mayr; K Mann; P Tegtmeyer
Journal:  Mol Carcinog       Date:  1992       Impact factor: 4.784

3.  Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication.

Authors:  J Bargonetti; P N Friedman; S E Kern; B Vogelstein; C Prives
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

4.  Oligomerization of oncoprotein p53.

Authors:  S Kraiss; A Quaiser; M Oren; M Montenarh
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

5.  The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins.

Authors:  W H Landschulz; P F Johnson; S L McKnight
Journal:  Science       Date:  1988-06-24       Impact factor: 47.728

6.  Identification of p53 as a sequence-specific DNA-binding protein.

Authors:  S E Kern; K W Kinzler; A Bruskin; D Jarosz; P Friedman; C Prives; B Vogelstein
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

7.  Presence of a potent transcription activating sequence in the p53 protein.

Authors:  S Fields; S K Jang
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

8.  The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.

Authors:  N P Pavletich; K A Chambers; C O Pabo
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

9.  Precise epitope mapping of the murine transformation-associated protein, p53.

Authors:  A Wade-Evans; J R Jenkins
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

10.  GCN4, a eukaryotic transcriptional activator protein, binds as a dimer to target DNA.

Authors:  I A Hope; K Struhl
Journal:  EMBO J       Date:  1987-09       Impact factor: 11.598

View more
  36 in total

1.  An ATP/ADP-dependent molecular switch regulates the stability of p53-DNA complexes.

Authors:  A L Okorokov; J Milner
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking.

Authors:  J M Stommel; N D Marchenko; G S Jimenez; U M Moll; T J Hope; G M Wahl
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

3.  Role of tumor suppressor p53 domains in selective binding to supercoiled DNA.

Authors:  Marie Brázdová; Jan Palecek; Dmitry I Cherny; Sabina Billová; Miroslav Fojta; Petr Pecinka; Borivoj Vojtesek; Thomas M Jovin; Emil Palecek
Journal:  Nucleic Acids Res       Date:  2002-11-15       Impact factor: 16.971

4.  Transcriptional regulation of the mdm2 oncogene by p53 requires TRRAP acetyltransferase complexes.

Authors:  Penny G Ard; Chandrima Chatterjee; Sudeesha Kunjibettu; Leon R Adside; Lisa E Gralinski; Steven B McMahon
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

5.  p53-induced DNA bending and twisting: p53 tetramer binds on the outer side of a DNA loop and increases DNA twisting.

Authors:  A K Nagaich; V B Zhurkin; S R Durell; R L Jernigan; E Appella; R E Harrington
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

6.  Hydrophobic side-chain size is a determinant of the three-dimensional structure of the p53 oligomerization domain.

Authors:  M McCoy; E S Stavridi; J L Waterman; A M Wieczorek; S J Opella; T D Halazonetis
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

7.  Nine hydrophobic side chains are key determinants of the thermodynamic stability and oligomerization status of tumour suppressor p53 tetramerization domain.

Authors:  M G Mateu; A R Fersht
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

8.  Targeted expression of the DNA binding domain of DRE-binding factor, a Drosophila transcription factor, attenuates DNA replication of the salivary gland and eye imaginal disc.

Authors:  F Hirose; M Yamaguchi; A Matsukage
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

9.  p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage.

Authors:  L Liu; D M Scolnick; R C Trievel; H B Zhang; R Marmorstein; T D Halazonetis; S L Berger
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

10.  Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.